BICUK: BK Virus and Renal Dysfunction in Postoperative/Posttraumatic Critically Ill Patients
Study Details
Study Description
Brief Summary
The purpose of this study is to find out whether acute renal failure is associated with BK virus reactivation in postoperative/posttraumatic critically ill patients with severe SIRS/sepsis and shock.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Polyomavirus BK virus (BKV) infection and nephropathy is a significant cause of allograft dysfunction in kidney transplantation. Clinical manifestation ranges from BK viremia and nephritis to renal dysfunction. It has been suggested that BK virus reactivation alone is not sufficient to cause BK viremia and nephropathy, thus a second hit is essential for kidney specific damage, such as an inflammatory reaction or ischemia. Critically ill postoperative/posttraumatic patients via the systemic inflammatory response syndrome (SIRS) and the compensatory antiinflammatory response syndrome (CARS) are at increased risk to develop organ dysfunctions, such as acute renal failure. CARS, reflecting postoperative/posttraumatic immunosuppression, may favor viral reactivation. However, prevalence of BK viremia in critically ill postoperative/posttraumatic patients has up to now not been systematically evaluated. Moreover, it is not known whether BK viremia is associated with a distinct biomarker pattern in these patients. Therefore, the present study is performed to clarify whether postoperative/posttraumatic immunosuppression is associated with BK viremia, and acute renal failure with BK virus reactivation, respectively.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Patients with non-septic shock Postoperative/posttraumatic surgical critically ill patients with non-septic shock with threatening acute renal failure |
|
Patients with septic shock Postoperative/posttraumatic surgical critically ill patients with septic shock with threatening acute renal failure |
Outcome Measures
Primary Outcome Measures
- Association between BK virus reactivation and acute renal dysfunction [Daily monitoring of acute renal failure, first day of acute renal dysfunction, first days on hemodiafiltration, first day after hemodiafiltration, before demission from intensive care unit or death.]
Secondary Outcome Measures
- Pattern of biomarkers and surface markers on leukocytes. [First day of acute renal dysfunction, first days on hemodiafiltration, first day after hemodiafiltration, before demission from intensive care unit or death.]
Eligibility Criteria
Criteria
Inclusion Criteria:
- Critically ill, postoperative/posttraumatic patients with threatening acute renal failure
Exclusion Criteria:
-
Life expectancy < 24 hours
-
Participation in other trials
-
Known or suspected pregnancy
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Clinic of Anesthesiology | Ulm | Germany | 89070 |
Sponsors and Collaborators
- University of Ulm
- University of Wuerzburg
Investigators
- Principal Investigator: Manfred Weiss, MD, MBA, University Hospital Ulm
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- Anae_ICU_Ulm_BKV